1. Home
  2. VRAX vs UGRO Comparison

VRAX vs UGRO Comparison

Compare VRAX & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • UGRO
  • Stock Information
  • Founded
  • VRAX 2013
  • UGRO 2014
  • Country
  • VRAX United Kingdom
  • UGRO United States
  • Employees
  • VRAX N/A
  • UGRO N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • UGRO Industrial Specialties
  • Sector
  • VRAX Health Care
  • UGRO Consumer Discretionary
  • Exchange
  • VRAX Nasdaq
  • UGRO Nasdaq
  • Market Cap
  • VRAX 7.3M
  • UGRO 8.8M
  • IPO Year
  • VRAX 2022
  • UGRO N/A
  • Fundamental
  • Price
  • VRAX $1.98
  • UGRO $0.69
  • Analyst Decision
  • VRAX
  • UGRO Strong Buy
  • Analyst Count
  • VRAX 0
  • UGRO 2
  • Target Price
  • VRAX N/A
  • UGRO $5.63
  • AVG Volume (30 Days)
  • VRAX 289.0K
  • UGRO 132.0K
  • Earning Date
  • VRAX 02-05-2025
  • UGRO 03-26-2025
  • Dividend Yield
  • VRAX N/A
  • UGRO N/A
  • EPS Growth
  • VRAX N/A
  • UGRO N/A
  • EPS
  • VRAX N/A
  • UGRO N/A
  • Revenue
  • VRAX $84,872.00
  • UGRO $70,320,066.00
  • Revenue This Year
  • VRAX $5,169.18
  • UGRO $17.15
  • Revenue Next Year
  • VRAX $66.97
  • UGRO $21.76
  • P/E Ratio
  • VRAX N/A
  • UGRO N/A
  • Revenue Growth
  • VRAX 7.03
  • UGRO 12.08
  • 52 Week Low
  • VRAX $0.60
  • UGRO $0.60
  • 52 Week High
  • VRAX $9.00
  • UGRO $2.84
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 48.26
  • UGRO 37.71
  • Support Level
  • VRAX $1.58
  • UGRO $0.72
  • Resistance Level
  • VRAX $1.92
  • UGRO $1.12
  • Average True Range (ATR)
  • VRAX 0.23
  • UGRO 0.12
  • MACD
  • VRAX -0.01
  • UGRO 0.01
  • Stochastic Oscillator
  • VRAX 43.99
  • UGRO 29.44

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About UGRO urban-gro Inc.

Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.

Share on Social Networks: